Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value
$5.51−0.26 (-4.51%)
Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –
Strata Critical Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Strata Critical Medical's gross margin for the twelve months ending Jun 30, 2026 was 20.6%. For fiscal 2025 it was 20.9%, against 20.2% the year before. The highest annual figure on record is 20.9% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.9% | +0.7 |
| FY2024 | Dec 31, 2024 | 20.2% | +1.4 |
| FY2023 | Dec 31, 2023 | 18.7% | −2.1 |
| FY2021 | Sep 30, 2021 | 20.8% | +10.9 |
| FY2020 | Sep 30, 2020 | 9.9% | −5.1 |
| FY2019 | Sep 30, 2019 | 15.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 21.0% | +1.0 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 21.0% | +1.3 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 17.5% | +3.7 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 23.6% | +2.7 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 20.0% | −4.1 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 19.6% | −0.1 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 13.8% | −5.2 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 20.8% | −1.0 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 24.1% | +7.1 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 19.7% | +3.9 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | 19.0% | −3.0 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 21.8% | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 17.0% | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 15.8% | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | 22.0% | – |
See a number that looks wrong?